Показати скорочений опис матеріалу

dc.contributor.author Obertynska, O
dc.date.accessioned 2025-12-07T09:19:20Z
dc.date.available 2025-12-07T09:19:20Z
dc.date.issued 2025
dc.identifier.citation Obertynska O. The impact of a chronic obstructive pulmonary disease diagnosis on the identification of heart failure / O. Obertynska, L. Rasputina, A. Solomonchuk // European Heart Journal. – 2025. – № 46. – P. 1453. – ESC Congress (Madrid, 29 August – 01 September 2025) uk_UA
dc.identifier.issn ISSN 0195-668X
dc.identifier.uri https://dspace.vnmu.edu.ua/123456789/10949
dc.description.abstract The prevalence of unrecognized HF in symptomatic COPD patients turned out to be 20 %, particularly in severe stages (GOLD 3or 4) underscores the need for routine cardiac evaluation in this population. NT-proBNP levels can be unexpectedly higher in COPD patients due to right ventricular strain and pulmonary hypertension, in the absence of left-sided heart failure making echocardiography essential for accurate diagnosis. Among patients with COPD, HF with preserved EF is the most common. The higher mMRC grade (≥3), older age, obesity, E/e' ratio (>13,5) predict hidden HF in COPD with persistent symptoms despite optimal COPD treatment uk_UA
dc.language.iso en uk_UA
dc.publisher European Heart Journal uk_UA
dc.subject Heart failure, chronic obstructive pulmonary disease, diagnosis Серцева недостатність, хронічне обструктивне захворювання легень, діагностика uk_UA
dc.title The impact of a chronic obstructive pulmonary disease diagnosis on the identification of heart failure uk_UA


Файли цього елементу

Даний матеріал зустрічається у наступних зібраннях

Показати скорочений опис матеріалу